MEFOXIN Side Effects

7019309-0 | Pulmonary Tuberculosis
on Sep 20, 2010 Female patient from KOREA, REPUBLIC OF , 44 years of age, was diagnosed with lung infection and was treated with Mefoxin (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary tuberculosis. Mefoxin dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ). Patient was hospitalized.

5873950-7 | Leukopenia, Sepsis
Patient was taking Mefoxin (View Usage). Patient had the following side effects: leukopenia, sepsis (What is sepsis?) on Aug 26, 2008 from UNITED STATES Additional patient health information: Male patient , 22 years of age, was diagnosed with prophylaxis, escherichia infection, acinetobacter infection and. Mefoxin dosage: . During the same period patient was treated with TIGECYCLINE (View Tigecycline Review and Tigecycline Label ).

5495314-0 | Anaphylactic Shock, Blood Pressure Decreased, Bradycardia
Adverse event was reported on Oct 19, 2007 by a Male patient taking Mefoxin (View Usage) (Dosage: ) . Location: AUSTRALIA , 69 years of age, weighting 165.3 lb, After Mefoxin was administered, patient had the following side effects: anaphylactic shock, blood pressure decreased, bradycardia. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5491788-X | Rash
on Oct 19, 2007 Female patient from UNITED STATES , 40 years of age, was treated with Mefoxin (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Mefoxin dosage: 1 Gram.


5278849-5 | Pyrexia, Rash Morbilliform
on Mar 22, 2007 Female patient from UNITED STATES , 53 years of age, was diagnosed with prophylaxis and was treated with Mefoxin (View Usage). Patient had the following side effects: pyrexia, rash morbilliform. Mefoxin dosage: .

5222354-9 | Bed Rest, Blood Potassium Decreased, Dehydration, Diarrhoea, Pulmonary Embolism, Pyrexia, Shock
Patient was taking Mefoxin (View Usage). After Mefoxin was administered, patient had the following side effects: bed rest, blood potassium decreased, dehydration, diarrhoea, pulmonary embolism (What is pulmonary embolism?), pyrexia, shock on Jan 24, 2007 from UNITED STATES Additional patient health information: Male patient , 29 years of age, was diagnosed with prophylaxis and. Mefoxin dosage: . During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ), REGLAN (View Reglan Review and Reglan Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ). Patient was hospitalized and became disabled.

5209139-4 | Pyrexia, Rash Morbilliform
Adverse event was reported on Jan 05, 2007 by a Female patient taking Mefoxin (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 53 years of age, Patient experienced the following unwanted or unexpected effects: pyrexia, rash morbilliform.

5110681-5 | Cardiac Arrest, Erythema Multiforme, Mycobacterial Infection, Seroma, Skin Infection
on Aug 30, 2006 Female patient from UNITED STATES , 21 years of age, was diagnosed with mycobacterium abscessus infection and was treated with Mefoxin (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), erythema multiforme, mycobacterial infection, seroma, skin infection. Mefoxin dosage: . During the same period patient was treated with VALGANCICLOVIR HYDROCHLORIDE (View Valganciclovir Hydrochloride Review and Valganciclovir Hydrochloride Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), KANAMYCIN (View Kanamycin Review and Kanamycin Label ). Patient was hospitalized.

5101464-0 | Breast Prosthesis User, Cardiac Arrest, Enterococcal Infection, Erythema Multiforme, Hypotension, Implant Site Effusion, Incision Site Infection, Lung Infection
on Aug 30, 2006 Female patient from UNITED STATES , 21 years of age, was diagnosed with mycobacterium abscessus infection and was treated with Mefoxin (View Usage). After Mefoxin was administered, patient had the following side effects: breast prosthesis user, cardiac arrest (What is cardiac arrest?), enterococcal infection, erythema multiforme, hypotension, implant site effusion, incision site infection, lung infection. Mefoxin dosage: . During the same period patient was treated with VALGANCICLOVIR HYDROCHLORIDE (View Valganciclovir Hydrochloride Review and Valganciclovir Hydrochloride Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), KANAMYCIN (View Kanamycin Review and Kanamycin Label ). Patient was hospitalized.

5053170-9 | Bronchospasm, Hypotension, Rash
Patient was taking Mefoxin (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, hypotension, rash (What is rash?) on Jul 10, 2006 from FRANCE Additional patient health information: Female patient , 70 years of age, was diagnosed with infection prophylaxis and. Mefoxin dosage: . During the same period patient was treated with SUCCINYLCHOLINE IODIDE (View Succinylcholine Iodide Review and Succinylcholine Iodide Label ), PROPOFOL (View Propofol Review and Propofol Label ), CISATRACURIUM BESYLATE (View Cisatracurium Besylate Review and Cisatracurium Besylate Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), NEFOPAM HYDROCHLORIDE (View Nefopam Hydrochloride Review and Nefopam Hydrochloride Label ).

5027895-5 | Acidosis, Clostridium Difficile Colitis, Deep Vein Thrombosis, Gastrointestinal Necrosis, Hypotension, Hypoxia, Ileal Perforation, Ileitis, Multi-organ Failure
Adverse event was reported on Mar 15, 2006 by a Male patient taking Mefoxin (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: acidosis, clostridium difficile colitis, deep vein thrombosis (What is deep vein thrombosis?), gastrointestinal necrosis, hypotension, hypoxia, ileal perforation, ileitis, multi-organ failure.

5026749-8 | Cardiac Arrest, Clostridium Difficile Sepsis, Colitis Pseudomembranous
on Jun 05, 2006 Female patient from UNITED STATES , child 5 years of age, was diagnosed with septic shock and was treated with Mefoxin (View Usage). After Mefoxin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), clostridium difficile sepsis, colitis pseudomembranous. Mefoxin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ).

4951122-8 | Acidosis, Clostridium Colitis, Deep Vein Thrombosis, Hypotension, Hypoxia, Ileal Perforation, Ileitis, Multi-organ Failure, Peritonitis
on Mar 15, 2006 Male patient from UNITED STATES , 80 years of age, was diagnosed with prophylaxis and was treated with Mefoxin (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, clostridium colitis, deep vein thrombosis (What is deep vein thrombosis?), hypotension, hypoxia, ileal perforation, ileitis, multi-organ failure, peritonitis. Mefoxin dosage: .

4789919-X | Acute Pulmonary Oedema, Hypotension, Tachycardia, Ventricular Hypokinesia
Patient was taking Mefoxin (View Usage). Patient had the following side effects: acute pulmonary oedema, hypotension, tachycardia, ventricular hypokinesia on Sep 30, 2005 from FRANCE Additional patient health information: Female patient , 16 years of age, was diagnosed with infection prophylaxis, asthma (What is asthma?), tachycardia and. Mefoxin dosage: . During the same period patient was treated with ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), PROPOFOL (View Propofol Review and Propofol Label ), REMIFENTANIL HYDROCHLORIDE (View Remifentanil Hydrochloride Review and Remifentanil Hydrochloride Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ).

4781408-1 | Clostridium Colitis, Colitis Ischaemic, Confusional State, Lactic Acidosis, Lethargy, Megacolon, Mental Status Changes
Adverse event was reported on Sep 22, 2005 by a Male patient taking Mefoxin (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?) and. Location: UNITED STATES , 88 years of age, After Mefoxin was administered, patient had the following side effects: clostridium colitis, colitis ischaemic, confusional state, lactic acidosis, lethargy, megacolon, mental status changes. Patient was hospitalized.

4590110-0 | Anxiety, Dyspnoea, Erythema, Feeling Hot, Swelling Face
on Feb 17, 2005 Female patient from , 66 years of age, weighting 209.4 lb, was treated with Mefoxin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dyspnoea, erythema, feeling hot, swelling face. Mefoxin dosage: .